Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis
Multiple Sclerosis International · 2010
DOI: 10.1155/2010/351045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis International, 2010. Verfasst von Damian Franzen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Berrenratherstr. 296, 50937 Köln, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Immunosuppressive therapy is an established therapeutic option in patients suffering from multiple sclerosis (MS). In an open nonrandomized study we serially assessed cardiac function in 30 consecutive patients with MS before, during, and after mitoxantrone therapy. Mitoxantrone (12 mg/m 2 ) was administered intravenously at 3-month intervals. Before each infusion, cardiac function was assessed by history taking, resting electrocardiogram, and echocardiography. Whereas no patient experienced clinical signs of heart failure, left ventricular pump function decreased continuously during mitoxantrone therapy and did not recover after cessation. The presented data suggest a dose-dependent and long-lasting toxic cardiac effect of low-dose mitoxantrone therapy in MS.
Autor:innen und Institutionen
- Berrenratherstr. 296, 50937 Köln, Germany.
Zitieren
APA
Franzen, D., Haus, A., & Hellmich, M. (2010). Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis. Multiple Sclerosis International. https://doi.org/10.1155/2010/351045
Vancouver
Franzen D, Haus A, Hellmich M. Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis. Multiple Sclerosis International. 2010. doi:10.1155/2010/351045
BibTeX
@article{Franzen2010,
author = {Franzen, Damian and Haus, Angelika and Hellmich, Martin},
title = {Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis},
journal = {Multiple Sclerosis International},
year = {2010},
doi = {10.1155/2010/351045}
}
EUVIMED